Fibrogen Stock Investor Sentiment
| FGEN Stock | USD 6.93 0.04 0.58% |
About 71 percent of all FibroGen's investors are curious in acquiring. The analysis of the overall investor sentiment regarding FibroGen suggests that quite a few traders are confidant. FibroGen's investing sentiment overview a quick insight into current market opportunities from investing in FibroGen. Many technical investors use FibroGen stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Comfort Level 71
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use FibroGen's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward FibroGen.
News SentimentBullish | Hype SentimentNeutral | Insider SentimentAcquiring |
FibroGen Historical Sentiment
Although FibroGen's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding FibroGen, such as negative comments on social media and news outlets, may cause fear in the market and push FibroGen's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of FibroGen.
FibroGen Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards FibroGen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of FibroGen's Stock prices. Below is the latest headlines and news related to FibroGen Stock. Current markets are strongly bullish. About 75% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about FibroGen that are available to investors today. This information is accessible both publicly - through FibroGen's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of FibroGen-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of FibroGen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of FibroGen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to FibroGen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive FibroGen alpha.
FibroGen Largest EPS Surprises
Earnings surprises can significantly impact FibroGen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-05-05 | 2025-03-31 | 0.02 | 0.05 | 0.03 | 150 | ||
2024-05-06 | 2024-03-31 | -0.42 | -0.33 | 0.09 | 21 | ||
2021-05-10 | 2021-03-31 | -0.87 | -0.78 | 0.09 | 10 | ||
2015-08-13 | 2015-06-30 | 0.73 | 0.83 | 0.1 | 13 | ||
2016-05-09 | 2016-03-31 | -0.56 | -0.45 | 0.11 | 19 | ||
2025-02-24 | 2024-12-31 | -0.2 | -0.08 | 0.12 | 60 |
There is far too much social signal, news, headlines, and media speculation about FibroGen that are available to investors today. This information is accessible both publicly - through FibroGen's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of FibroGen-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of FibroGen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of FibroGen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to FibroGen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive FibroGen alpha.
FibroGen Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Stevanato Group Q1 Earnings and Revenues Top Estimates | 05/08/2025 |
2 | FibroGen outlines 185M China divestiture and extended cash runway into 2027 while advancing prostate cancer pipeline | 05/13/2025 |
3 | Insider Trading | 06/04/2025 |
4 | FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors FGEN Stock News | 06/09/2025 |
5 | FibroGen Announces 1-for-25 Reverse Stock Split FGEN Stock News | 06/12/2025 |
6 | Adobe, FibroGen And Other Big Stocks Moving Lower In Fridays Pre-Market Session | 06/13/2025 |
7 | FibroGen Trading Down 6.7 percent Whats Next | 06/17/2025 |
8 | Acquisition by Schoeneck James A of 23567 shares of FibroGen at 5.07 subject to Rule 16b-3 | 06/30/2025 |
9 | Acquisition by Juan Graham of 220000 shares of FibroGen at 1.21 subject to Rule 16b-3 | 07/18/2025 |
10 | Is FibroGen Inc. a growth stock or a value stock - Unmatched market performance - jammulinksnews.com | 07/28/2025 |
Check out FibroGen Hype Analysis, FibroGen Correlation and FibroGen Performance. To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FibroGen. If investors know FibroGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FibroGen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.536 | Earnings Share (30.00) | Revenue Per Share | Quarterly Revenue Growth (0.89) | Return On Assets |
The market value of FibroGen is measured differently than its book value, which is the value of FibroGen that is recorded on the company's balance sheet. Investors also form their own opinion of FibroGen's value that differs from its market value or its book value, called intrinsic value, which is FibroGen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FibroGen's market value can be influenced by many factors that don't directly affect FibroGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FibroGen's value and its price as these two are different measures arrived at by different means. Investors typically determine if FibroGen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FibroGen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.